|Articles|November 2, 2022

Veeva and Merck Announce Partnership

Ten-year partnership will help Merck reduce operational costs and deliver value to patients, HCPs.

Veeva announced a ten-year strategic partnership agreement with Merck that builds on the existing 12-year partnership between the companies. Under the terms of the agreement, Merck will select Veeva products when they are fit for purpose. Veeva will provide Merck with a strategic pricing approach and Merck will have input into Veeva's product roadmap.

Read more about the partnership here.


Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content